| P50 | author | Greg N. Fuller | Q37370656 |
| P2093 | author name string | Wei Zhang | |
| | Dima Suki | |
| | Ganesh Rao | |
| | Yuhui Yang | |
| | Daniel W Fults | |
| | Tiffany Doucette | |
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| | Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. | Q48493738 |
| | Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas | Q48540461 |
| | Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors. | Q48564486 |
| | PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors. | Q48791387 |
| | What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator | Q48939992 |
| | Necrosis as a prognostic factor in glioblastoma multiforme | Q49057512 |
| | Expression of bcl-2 in small cell lung carcinoma cells. | Q54218040 |
| | Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death. | Q55473040 |
| | Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma. | Q55476546 |
| | A matter of life and death | Q63408384 |
| | BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma | Q73555358 |
| | Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system | Q81469233 |
| | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 |
| | Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma | Q24670606 |
| | The 2007 WHO classification of tumours of the central nervous system | Q24685772 |
| | Proliferation, cell cycle and apoptosis in cancer | Q28189476 |
| | Malignant astrocytic glioma: genetics, biology, and paths to treatment | Q29618156 |
| | The Bcl-2 protein family: arbiters of cell survival | Q29618158 |
| | Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations | Q30885944 |
| | AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer | Q33992717 |
| | Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation | Q34223630 |
| | Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis | Q34786608 |
| | PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo | Q35080265 |
| | BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy | Q35454275 |
| | Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin | Q35763574 |
| | Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice | Q35801259 |
| | Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo | Q35829391 |
| | Insulin-like growth factor binding protein 2 promotes glioma development and progression | Q35880328 |
| | Platelet-derived growth factor (PDGF) and glial tumorigenesis | Q36247732 |
| | Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response | Q36416744 |
| | Bcl-2-family proteins and hematologic malignancies: history and future prospects | Q36508817 |
| | The prognostic influence of bcl-2 in malignant glioma | Q36644672 |
| | Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma | Q36825199 |
| | Bcl-2 family proteins and cancer | Q37310180 |
| | Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics | Q37761935 |
| | Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. | Q38302138 |
| | Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. | Q38351653 |
| | Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins | Q39956386 |
| | Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant glioma | Q40070342 |
| | BCL-2-induced glioma cell invasiveness depends on furin-like proteases | Q40483596 |
| | Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis | Q40511321 |
| | Antisense-mediated inhibition of the bcl-2 gene induces apoptosis in human malignant glioma | Q40877693 |
| | Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice | Q40881142 |
| | c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice | Q41589752 |
| | Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis | Q42827324 |
| | Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice | Q48148081 |
| | Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma | Q48200427 |
| | BCL-2 promotes migration and invasiveness of human glioma cells | Q48318360 |
| | BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study | Q48482815 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oligodendroglioma | Q1318384 |
| | murine model | Q122890741 |
| P304 | page(s) | 2093-2103 | |
| P577 | publication date | 2011-03-04 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma | |
| P478 | volume | 129 | |